Skip to main content
. 2017 Aug 14;4(3):ofx167. doi: 10.1093/ofid/ofx167

Table 3.

Hazard Ratio of Mortality by Urinary LAM Grade Among ART-Naive HIV-Infected South African Adults

Screening Test Number of Deaths/ Number at Risk (%) Unadjusted Models Adjusted Modelsa
Hazard Ratio (95% CI) P Value P Value for Trend Hazard Ratio (95% CI) P Value P Value for Trend
All Participants <.0001 <.0001
 No evidence of TB and LAM-negative 42/504 (8.3) Ref. Ref.
 Evidence of TB and LAM-negative 18/129 (14.0) 1.71 (0.99–2.98) .06 1.54 (0.88–2.68) .13
 Urine LAM 1+ grade 3/14 (21.4) 2.74 (0.85–8.83) .09 2.57 (0.79–8.38) .12
 Urine LAM 2+ grade 4/13 (30.8) 4.12 (1.48–11.5) .007 3.41 (1.22–9.57) .02
 Urine LAM ≥3+ grade 10/23 (43.5) 6.88 (3.45–13.7) <.0001 5.02 (2.48–10.2) <.0001
Participants with CD4 ≤200 cells/mm3 <.0001 .0005
 No evidence of TB and LAM-negative 33/233 (14.2) Ref. Ref.
 Evidence of TB and LAM-negative 15/100 (15.0) 1.06 (0.57–1.94) .86 0.99 (0.53–1.83) .96
 Urine LAM 1+ grade 3/12 (25.0) 1.83 (0.56–5.95) .32 1.74 (0.53–5.72) .36
 Urine LAM 2+ grade 4/10 (40.0) 3.17 (1.12–8.95) .03 2.71 (0.95–7.71) .06
 Urine LAM ≥3+ grade 9/19 (47.4) 4.51 (2.15–9.43) <.0001 3.61 (1.69–7.71) .0009
Participants With CD4 ≤100 cells/mm3 .0003 .003
 No evidence of TB and LAM-negative 27/164 (16.5) Ref. Ref.
 Evidence of TB and LAM-negative 8/69 (11.6) 0.69 (0.31–1.51) .35 0.65 (0.29–1.43) .31
 Urine LAM 1+ grade 3/8 (37.5) 2.45 (0.74–8.09) .13 2.10 (0.63–7.05) .21
 Urine LAM 2+ grade 4/8 (50.0) 3.51 (1.23–10.0) .02 2.96 (1.01–8.70) .05
 Urine LAM ≥3+ grade 8/17 (47.1) 3.70 (1.68–8.14) .001 3.04 (1.34–6.91) .008

Abbreviations: ART, antiretroviral therapy; CI, confidence interval; HIV, human immunodeficiency virus; LAM, lipoarabinomannan; Ref., ; TB, tuberculosis.

aAdjusted by age, sex, education, and smoking status.